The DOI matches its Crossref record; 338 of the 338 references it cites were found in a registry or an index.
Hyperglycemia and Glycation in Diabetic Complications
Abstract
Diabetes mellitus is a multifactorial disease, classically influenced by genetic determinants of individual susceptibility and by environmental accelerating factors, such as lifestyle. It is considered a major health concern, as its incidence is increasing at an alarming rate, and the high invalidating effects of its long-term complications affect macro- and microvasculature, heart, kidney, eye, and nerves. Increasing evidence indicates that hyperglycemia is the initiating cause of the tissue damage occurring in diabetes, either through repeated acute changes in cellular glucose metabolism, or through the long-term accumulation of glycated biomolecules and advanced glycation end products (AGEs). AGEs represent a heterogeneous group of chemical products resulting from a nonenzymatic reaction between reducing sugars and proteins, lipids, nucleic acids, or a combination of these. The glycation process (glucose fixation) affects circulating proteins (serum albumin, lipoprotein, insulin, hemoglobin), whereas the formation of AGEs implicates reactive intermediates such as methylglyoxal. AGEs form cross-links on long-lived extracellular matrix proteins or react with their specific receptor RAGE, resulting in oxidative stress and proinflammatory signaling implicated in endothelium dysfunction, arterial stiffening, and microvascular complications. This review summarizes the mechanism of glycation and of AGEs formation and the role of hyperglycemia, AGEs, and oxidative stress in the pathophysiology of diabetic complications. Antioxid. Redox Signal. 11, 3071–3109. Introduction Oxidative Stress and Metabolic Dysfunction in Acute Hyperglycemia and Diabetes Oxidative stress: Generalities Acute hyperglycemia, glycemia variability, and oxidative stress Acute hyperglycemia and oxidative stress in vivo High glucose induces ROS generation in cultured cells Chronic hyperglycemia and oxidative stress Hyperglycemia and mitochondrial free radical production ROS in the pathogenic mechanisms of diabetes complications Glycation and AGEs: Formation, Excretion, and Biologic Effects Glycation and AGEs formation Chemical mechanisms of glycation and AGEs formation Exogenous glycation and AGEs formation Endogenous glycation and AGEs formation Defenses against glycation and AGEs Glucose has low glycating activity The digestive barrier limits the absorption of diet-derived AGEs Cellular defense mechanisms Low-molecular-weight agents Reduced glutathione Carbon monoxide Bilirubin and biliverdin reductase Uric acid Vitamins Cellular antioxidant defenses Superoxide dismutase Catalase Glutathione peroxidase Glutathione reductase and glutathione S-transferase Heme oxygenase Thioredoxin Cellular defenses against glycation and AGEs Amadoriases Glyoxalase system Proteolytic degradation by proteasome Role of the kidney and liver in the excretion of AGEs Molecular and cellular consequences of glycation and AGEs formation Glycation of circulating proteins Hemoglobin Insulin Serum albumin Lipoproteins LDL and VLDL Increased sensitivity to oxidation Foam cell formation 3072Glycated LDL-mediated inflammatory signaling Mitogenic and apoptotic effects Alteration of platelet function and procoagulant activity HDL Molecular and cellular effects of AGEs modification RAGE- (and related receptors)-dependent effects RAGE Structure of RAGE RAGE gene and polymorphisms Alternative splicing RAGE expression Ligand specificity AGEs S100 calgranulins High-mobility-group box protein-1 Amyloid-β peptide and β-sheet fibrils AGEs receptors and scavenger receptors AGE-R1 or OST-48 (oligosaccharyl transferase-4) AGE-R2 (80K-H or PRKCSH) AGE-R3 or galectin-3 Scavenger receptors CD36 MSR-A SR-B1 LOX-1 Other AGEs-binding proteins AGE/RAGE-dependent cellular effects NF-κB activation and inflammatory signaling Arachidonic acid cascade Nitric oxide synthase Endothelium activation Cell proliferation Angiogenesis Cytokines, growth factors, and chemokines secretion Differentiation Thrombosis Apoptosis RAGE-mediated immune responses RAGE-independent effects Biologic consequences of AGEs formation on extracellular matrix Biologic consequences of AGEs formation on cellular proteins Biologic consequences of AGEs formation on DNA Biologic consequences of AGEs-modified lipids Glycation and AGEs in the pathophysiology of diabetes complications Pathophysiologic role of dietary AGEs Accelerated diabetic atherosclerosis Arterial stiffening Restenosis Microvascular complications Retinopathy Nephropathy Neuropathy Wound healing Alzheimer's disease Cancers Osteoporosis Conclusions and Perspectives3073
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Toth, C., Rong, L. L., Yang, C., Martinez, J., Song, F., Ramji, N., Brussee, V., Liu, W., Durand, J., Nguyen, M. D., et al. (2008) · Diabetes · doi:10.2337/db07-0339 · Cited by 187
Retracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · cited 4×
“Cultured endothelial and mesangial cells grown in normal (5 mM) and placed in high glucose (25–30 mM) medium exhibit an increase of intracellular ROS (124, 234) and repeated fluctuations of glucose concentration (between 5 and 25 mM) on cultured cells also induce a higher ROS increase than that induced by constant hig…”
InfluentialRole of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. W. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,793
Diabetes, oxidative stress, and antioxidants: A review
Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10058 · Cited by 3,124
SHEEHAN, D., MEADE, G., FOLEY, V. M., & DOWD, C. A. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600001 · Cited by 3,057
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · cited 1×
“It may be noted that glucose is less efficient than the other reducing monosaccharides (307).”
Cited by
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Markers of Oxidative Stress during Diabetes Mellitus
Tiwari, B. K., Pandey, K. B., Abidi, A. B., & Rizvi, S. I. (2013) · Journal of Biomarkers · doi:10.1155/2013/378790 · Cited by 517
“Oxidative stress acts as mediator of insulin resistance and its progression to glucose intolerance and installation of diabetesmellitus, subsequently favouring the appearance of atherosclerotic complications, and contributes to rise in many micro- and macrovascular complications [21].”
BackgroundPathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
Self-citationPalsamy, P., & Subramanian, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.008 · Cited by 380
Glucosensing and glucose homeostasis: From fish to mammals
Polakof, S., Mommsen, T. P., & Soengas, J. L. (2011) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2011.07.006 · Cited by 295
Molecular Basis of Arterial Stiffening: Role of Glycation – A Mini-Review
Sell, D. R., & Monnier, V. M. (2012) · Gerontology · doi:10.1159/000334668 · Cited by 282
Role of advanced glycation end products in carcinogenesis and their therapeutic implications
Schröter, D., & Höhn, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130145549 · Cited by 126
“Urribarri and coworkers found that about 30% of ingested AGEs accumulate in the human body [46], while Koschinsky et al.”
BackgroundGuerrero, E., Vasudevaraju, P., Hegde, M. L., Britton, G. B., & Rao, K. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8328-z · Cited by 121
Gamas, L., Matafome, P., & Seiça, R. (2015) · Journal of Diabetes Research · doi:10.1155/2015/359159 · Cited by 114
Ashraf, J. M., Ahmad, S., Choi, I., Ahmad, N., Farhan, M., Tatyana, G., & Shahab, U. (2015) · IUBMB Life · doi:10.1002/iub.1450 · Cited by 106
Rojas, A., Añazco, C., González, I., & Araya, P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy012 · Cited by 82
Bebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M., Lachin, J. M., & the DCCT/EDIC Research Group (2019) · Diabetes Care · doi:10.2337/dc18-1613 · Cited by 62
Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity
Baptista Pereira, P., Torrejón, E., Ferreira, I., Carvalho, A. S., Teshima, A., Sousa-Lima, I., Beck, H. C., Costa-Silva, B., Matthiesen, R., Macedo, M. P., et al. (2024) · Nutrients · doi:10.3390/nu16050736 · Cited by 6
Metadata
- Authors
- Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2009-12
- Volume
- 11
- Issue
- 12
- Pages
- 3071-3109
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2094142721
- Cited by
- 421
- References
- 338
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.